Author

Eiji Yoden

Observed institution: JCR Pharmaceuticals (Japan)

OpenAlex ID: A5000508009

A Blood-Brain-Barrier-Penetrating Anti-human Transferrin Receptor Antibody Fusion Protein for Neuronopathic Mucopolysaccharidosis II

2018 · Hiroyuki Sonoda, Hideto Morimoto, et al. · Molecular Therapy · 197

Clearance of heparan sulfate in the brain prevents neurodegeneration and neurocognitive impairment in MPS II mice

2021 · Hideto Morimoto, Sachiho Kida, et al. · Molecular Therapy · 35

Enzyme replacement with transferrin receptor-targeted α-L-iduronidase rescues brain pathology in mucopolysaccharidosis I mice

2023 · Sachiho Kida, Yuri Koshimura, et al. · Molecular Therapy — Methods & Clinical Development · 25

Nonclinical safety evaluation of pabinafusp alfa, an anti-human transferrin receptor antibody and iduronate-2-sulfatase fusion protein, for the treatment of neuronopathic mucopolysaccharidosis type II

2021 · Ryuji Yamamoto, Eiji Yoden, et al. · Molecular Genetics and Metabolism Reports · 19

Non-clinical evaluation of JR-051 as a biosimilar to agalsidase beta for the treatment of Fabry disease

2018 · Hideto Morimoto, Yae Ito, et al. · Molecular Genetics and Metabolism · 11

Transferrin Receptor-Targeted Iduronate-2-sulfatase Penetrates the Blood-Retinal Barrier and Improves Retinopathy in Mucopolysaccharidosis II Mice

2023 · Atsushi Imakiire, Hideto Morimoto, et al. · Molecular Pharmaceutics · 7

A transferrin receptor-targeted α-L-fucosidase, JR-471, reduced core-fucosylated glycoasparagine in the brain and preserved motor function in a murine model of fucosidosis

2026 · Tomomi Masuda, Eiji Yoden, et al. · Molecular Genetics and Metabolism

Recovery of retinal function in MPS II mice by treatment with pabinafusp alfa

2024 · Atsushi Imakiire, Hideto Morimoto, et al. · Molecular Genetics and Metabolism

A fusion protein of anti-human transferrin receptor antibody and alfa-L-fucosidase 1 is a prospective candidate for the treatment of the symptoms in CNS and visceral tissues of fucosidosis

2023 · Eiji Yoden, Takashi Onouchi, et al. · Molecular Genetics and Metabolism

Life-span extension in Krabbe disease mice by treatment with a transferrin receptor-targeted galactocerebrosidase

2023 · Atsushi Imakiire, Yasunori Sugano, et al. · Molecular Genetics and Metabolism

Reduction of heparan sulfate in the brain by pabinafusp alfa results in prevention of neurodegeneration and neurocognitive impairment in a mouse model of mucopolysaccharidosis type II

2021 · Hideto Morimoto, Sachiho Kida, et al. · Molecular Genetics and Metabolism

Blood-brain barrier-penetrating iduronate-2-sulfatase reduces brain glycosaminoglycans in mouse model of mucopolysaccharidosis type II

2018 · Hiroyuki Sonoda, Hideto Morimoto, et al. · Molecular Genetics and Metabolism

Novel quantification methods for globotriaosylceramide and globotriaosylsphingosine as biomarkers of Fabry disease

2015 · Noboru Tanaka, Hideto Morimoto, et al. · Molecular Genetics and Metabolism

The characterization of mouse model of mucopolysaccharidosis type II

2015 · Masafumi Kinoshita, Hideto Morimoto, et al. · Molecular Genetics and Metabolism

Works count: 14

Citation count: 294

H-index: 6

I10-index: 5